SCHEMBL6630664

SCHEMBL6630664

O=C(NC[C]1CCCCCCC1)c1cc(-c2ccccc2)nc2ccccc12.[CH2].[CH2]

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR3 P29371 2/20 0.72
LMNA P02545 3/20 0.65
MAPK1 P28482 1/20 0.65
ALDH1A1 P00352 6/20 0.64
KDM4E B2RXH2 4/20 0.64
MEN1 O00255 2/20 0.64
KMT2A Q03164 2/20 0.64
GAA P10253 1/20 0.64
POLB P06746 1/20 0.63
SMN1; SMN2 Q16637 1/20 0.62
HTT P42858 2/20 0.61
NPC1 O15118 1/20 0.61
TP53 P04637 1/20 0.61
RAB9A P51151 1/20 0.61
L3MBTL1 Q9Y468 2/20 0.61
CYP2C9 P11712 1/20 0.60
TSHR P16473 2/20 0.60
MAPT P10636 1/20 0.59
CYP3A4 P08684 1/20 0.57
HPGD P15428 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6450086 0.84 TACR3 (1.00) TACR3LMNAMAPK1ALDH1A1KDM4E
SCHEMBL28806102 0.81 TACR3 (0.83) TACR3LMNAMAPK1ALDH1A1KDM4E
SCHEMBL10391576 0.79 TACR3 (0.76) TACR3LMNAMAPK1ALDH1A1KDM4E
SCHEMBL6447770 0.79 TACR3 (0.75) TACR3LMNAMAPK1ALDH1A1KDM4E
SCHEMBL4497529 0.78 NSD2 (0.57)
SCHEMBL23722853 0.78 ACACB (0.66) TACR3LMNAMAPK1ALDH1A1KDM4E
SCHEMBL28511608 0.77 MAPT (0.82) TACR3LMNAALDH1A1KDM4EMEN1
SCHEMBL28806105 0.77 TACR3 (0.76) TACR3LMNAMAPK1ALDH1A1KDM4E
SCHEMBL14970878 0.77 KDM4E (0.75) LMNAALDH1A1KDM4EMEN1KMT2A
SCHEMBL14133006 0.77 TACR3 (0.72) TACR3LMNAALDH1A1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1490341-A1 NOVEL ADAMANTANE DERIVATIVES AstraZeneca AB (SE) 2004-12-29 EP disclosed
WO-2003080579-A1 NOVEL ADAMANTANE DERIVATIVES ASTRAZENECA AB (SE) 2003-10-02 WO disclosed